Yunhu Technology, a Hangzhou, China-based internet platform for primary medical service, secured tens of millions RMB in series A+ financing.
The round was led by China Creation Ventures with participation from existing backers Vision+ Capital, Morningside Venture Capital, Cash Capital and BioTrack Capital.
Founded in 2017 by Xiaobin Chen, Yunhu Technology has created an internet platform for medical examination that connects more than a thousand local medical institutions.
The company has the following three major product lines:
– a series of Platform-based Testing Products which is highly comprehensive and authoritative;
– a SaaS based LIS\HIS platform which is designed for local medication institution to use; and
– a 3rd party cold chain logistic to support the efficient blood/drug delivery.
Yunhu Technology counts more than 800 employees across its offices in Beijing, Shanghai, and Hangzhou. It previously got a pre-Series A round investment from Vision+ Capital and Morningside Venture Capital, and took on RMB 8 million from Cash Capital and RMB 30 million from BioTrack Capital in Series A round financing.